Abstract
ObjectivesTo evaluate the cost-effectiveness of immediate treatment with ranibizumab in patients with neovascular age-related macular degeneration (nAMD) with good (better than 6/12) starting visual acuity compared with current UK clinical...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have